• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Health Products Association - China Executive Director Reflects on Market Dynamics, Challenges

    Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention

    New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance

    Tapping Functional Beverages to Meet Modern Wellness Needs

    Adaptogens: Where Ancient Remedies Meet Modern Wellness Products
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Pharmavite Expands in Ohio with $200 Million Investment

    Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company

    Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products

    NOW Identifies Misleading Certificate of Analysis for Supplements Sold on Amazon

    Kensing Acquires Vitae Naturals
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Kensing Acquires Vitae Naturals

    Lynside® Forte B offers full range of B-vitamin benefits with nutritional yeast

    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise

    Shiitake Mushroom Extract Appears Helpful in HPV Infections

    United Plant Savers Launches First Film Festival
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Pharmavite Expands in Ohio with $200 Million Investment

    Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company

    Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products

    NOW Identifies Misleading Certificate of Analysis for Supplements Sold on Amazon

    Kensing Acquires Vitae Naturals
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products

    Lynside® Forte B offers full range of B-vitamin benefits with nutritional yeast

    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise

    Shiitake Mushroom Extract Appears Helpful in HPV Infections

    Upcycled Coffeeberry® Cascara Offers Versatility in Functional Beverage Development
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Atlantia Clinical Trials

    Bioactive Resources

    Botanic Healthcare LLC

    Ecuadorian Rainforest

    Sabinsa Corporation
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Atlantia Clinical Trials

    Bioactive Resources

    Botanic Healthcare LLC

    Ecuadorian Rainforest

    Sabinsa Corporation
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    A Spicy Possibility

    Researchers test curcumin’s capacity to thwart the progress of Alzheimer’s disease.

    Related CONTENT
    • EuroPharma Supports ABC Educational Mission through Turmeric Adoption
    • Colon & Bowel Probiotic Targets Healthy Flora
    • Terry Naturally Introduces CuraMed Brain

    • EuroPharma Presents GingerMed + Turmerones
    • EuroPharma Introduces Sucontral D for Healthy Blood Sugar Balance
    Joanna Cosgrove05.05.11
    If the outcome of a recent research endeavor proves fruitful, Alzheimer’s disease may benefit from a component of a common Indian food ingredient. Curcumin, a component of turmeric, will be the subject of a year-long clinical study designed to gauge the ingredient’s ability to prevent or delay the expected declines of Alzheimer’s disease (AD), a degenerative condition that ranks as the sixth leading cause of death in the U.S. and affects an estimated 5.3 million Americans. 

    The study will be led by Professor Ralph Martins, PhD, a recognized leader in Alzheimer’s research, at the Centre of Excellence for Alzheimer’s Disease Research and Care, Edith Cowan University in Perth, Australia, where Dr. Martins has served as head of the Sir James McCusker Unit for Alzheimer’s Disease Research for more than 20 years.
     
    Known for his part in successfully isolating beta amyloid protein responsible for forming the amyloid plaque deposits in the brain—a characteristic diagnostic feature of Alzheimer’s disease—Dr. Martins later went onto demonstrate that the Alzheimer’s brain is under oxidative stress, which is now recognized to mediate the action of beta amyloid to cause Alzheimer's. He is also working to develop an early diagnostic blood test to effectively prevent and/or treat this devastating degenerative brain disease.
     
    Curcumin studies in animal models of Alzheimer's have demonstrated that it can play a significant role in the destruction of beta amyloid plaque. It is also a powerful antioxidant, with an ORAC value of 159,277 per 100 gm, as determined by the United States Department of Agriculture (USDA). Other studies have shown that curcumin plays a role in neuronal regeneration.
     
    In the past studies however, there have been significant problems with curcumin absorption and as a result, clinical work with plain curcumin has required very high dosing. To that end, the type of curcumin to be used in Dr. Martins’ study will be a special bioavailable form of curcumin called BCM-95, which is exclusively distributed as CuraMedin the US by EuroPharma.
     
    “I chose BCM-95 curcumin for this human study because it has published human bioavailability data,” explained Dr. Martins in a press release. “Therefore, I can use a reasonable amount and expect that the serum levels will achieve a therapeutic range for a significant period of time.”
     
    Researchers are currently recruiting participants with mild cognitive impairment (MCI) to be followed for 12 months, with periodic assessment of brain function and memory, as well as blood and cerebrospinal fluid biomarkers. One group of participants will be dosed with three 500 mg BCM-95 curcumin twice daily. There will also be a placebo group. The completion of the study is projected to be June 2013.
     
    Cheryl Myers, who is chief of scientific affairs at EuroPharma and will be working closely with Dr. Martins through the course of the study, told Nutraceuticals World that there are two goals set for this study. “The first hypothesis to prove is that it is expected that BCM-95 curcumin will significantly slow the progression of dementia,” she said. “The second is that there will be a significant change in blood biomarkers having to do with destruction of beta amyloid proteins that form plaque on the brain.”
     
    Curcumin’s Connection to Alzheimer's
     
    Researchers hope the design of their study will enable them to tap into curcumin’s powerful antioxidant and anti-inflammatory properties. “Curcumin is a super-potent antioxidant (ORAC value is 159,277 per 100 grams. By comparison, blueberries are a bit over 8,000 per 100 grams),” said Ms. Myers. “It has been proven that the Alzheimer’s brain is under inordinate amounts of oxidative stress, which is partly neutralized by potent antioxidants.”
     
    She also highlighted curcumin’s powerful anti-inflammatory properties. “Curcumin addresses inflammation by modulating several inflammation pathways in the body, as opposed to prescription and OTC drugs, which generally address only one pathway,” she said. “Individuals with higher levels of systemic inflammation are at higher risk for Alzheimer's and it has been shown that there are inflammatory characteristics in the development of the disease.”
     
    Ms. Myers said one of the most exciting scientific findings of the past 50 years is the discovery that certain brain regions make new neurons (brain cells) throughout life and added that curcumin has been shown to actively support the process of creation of new brain cells, a process called neurogenesis.
     
    The hippocampus region of the brain, associated with learning and memory functions, is a major site of adult neurogenesis, and is also the structure affected in various neurologic diseases.”Scientific evidence suggests that adult neurogenesis is important in neurologic disorders such as Alzheimer's, because hippocampal structure and function are dysregulated in this disorder,” explained Ms. Myers. “Yet another way in which curcumin may address Alzheimer's is the destruction of beta amyloid plaque, a structural feature of advancing Alzheimer's in which abnormal protein deposits accumulate in the brain that further disrupts cell to cell communication and disrupts thinking.
     
    “In a mouse model of Alzheimer's there was a 30% regression in beta amyloid plaque brain deposits after only seven days of curcumin administration,” she continued. “Therefore, curcumin is perfectly suited for studies on Alzheimer's as it effectively addresses so many aspects of the disease simultaneously.”
    Related Searches
    • Proteins
    • Protein
    • Nutraceuticals
    • Antioxidants
    Related Knowledge Center
    • Research
    • Cognitive Function
    • Antioxidants
    Suggested For You
    EuroPharma Supports ABC Educational Mission through Turmeric Adoption EuroPharma Supports ABC Educational Mission through Turmeric Adoption
    Colon & Bowel Probiotic Targets Healthy Flora Colon & Bowel Probiotic Targets Healthy Flora
    Terry Naturally Introduces CuraMed Brain
 Terry Naturally Introduces CuraMed Brain

    EuroPharma Presents GingerMed + Turmerones EuroPharma Presents GingerMed + Turmerones
    EuroPharma Introduces Sucontral D for Healthy Blood Sugar Balance EuroPharma Introduces Sucontral D for Healthy Blood Sugar Balance
    EuroPharma Launches Terrific Zzzz for Sleep Support EuroPharma Launches Terrific Zzzz for Sleep Support
    Genetic Engineering & GMOs: What You Rarely Hear Genetic Engineering & GMOs: What You Rarely Hear
    KSM-66 Awarded KSM-66 Awarded 'Product Innovation in Botanicals' by Frost & Sullivan
    Amin Talati Welcomes New Partner Amin Talati Welcomes New Partner
    BCM-95 Curcumin Selected For Alzheimer’s Study BCM-95 Curcumin Selected For Alzheimer’s Study
    BCM-95 Curcumin Selected For Alzheimer’s Study BCM-95 Curcumin Selected For Alzheimer’s Study
    The Road to Pain Relief The Road to Pain Relief
    ORAC-15,000 ORAC-15,000
    The Research Process: Bringing ORAC to a New Level The Research Process: Bringing ORAC to a New Level
    Making Health Manly Making Health Manly

    Related Breaking News

    • Breaking News | Herbs & Botanicals | Industry & Market News

      EuroPharma Supports ABC Educational Mission through Turmeric Adoption

      The turmeric rhizome has a long history of use in Ayurveda and traditional Chinese medicine.
      05.02.17

    • Dietary Supplements | Digestive Health | Probiotics & Prebiotics | Products

      Colon & Bowel Probiotic Targets Healthy Flora

      New product from EuroPharma contains proprietary probiotic formula, FloraSure.
      07.11.16

    • Cognitive Function | Dietary Supplements | Products
      Terry Naturally Introduces CuraMed Brain


      Terry Naturally Introduces CuraMed Brain


      Targeted ingredients support mental agility, focus and clarity.
      06.21.16


    • Dietary Supplements | Inflammation | Products
      EuroPharma Presents GingerMed + Turmerones

      EuroPharma Presents GingerMed + Turmerones

      Combination designed for cellular protection and healthy inflammation response.
      05.25.16

    • Diabetes & Blood Sugar Management | Dietary Supplements | Minerals | Products | Research | Vitamins
      EuroPharma Introduces Sucontral D for Healthy Blood Sugar Balance

      EuroPharma Introduces Sucontral D for Healthy Blood Sugar Balance

      Sucontral D is based on an extract of polyphenols from the herb Hintonia latiflora.
      03.28.16

    Loading, Please Wait..
    Trending
    • 3 grams of Omega-3s May be Optimal Dose for Reducing Blood Pressu
    • Three Grams Of Omega-3s May Be Optimal Dose For Reducing Blood Pressure
    • High Blood DHA Levels Linked To 49% Reduced Risk Of Alzheimer’s
    • CoQ10 And Royal Jelly Supplementation May Improve High Intensity Exercise
    • First Day Life Shuts Down Children's Behavioral, Cognitive Health Claims Following Challenge
    Breaking News
    • Pharmavite Expands in Ohio with $200 Million Investment
    • Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company
    • Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products
    • NOW Identifies Misleading Certificate of Analysis for Supplements Sold on Amazon
    • Kensing Acquires Vitae Naturals
    View Breaking News >
    CURRENT ISSUE

    June 2022

    • Tapping Functional Beverages to Meet Modern Wellness Needs
    • Adaptogens: Where Ancient Remedies Meet Modern Wellness Products
    • New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance
    • Health Products Association - China Executive Director Reflects on Market Dynamics, Challenges
    • Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Pharmavite Expands in Ohio with $200 Million Investment
    Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company
    Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products
    Coatings World

    Latest Breaking News From Coatings World

    Azelis Acquires Chemical Partners, Strengthens Leadership in Africa and Middle East
    Emmanuelle Bromet Named Arkema Sustainable Development VP
    ROSS Planetary Dual Dispersers Have Unique Processing Flexibility
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—July 2
    OmniGuide Awarded FDA Clearance for RevoLix Hybrid Thulium Laser
    Pancryos Forges License Agreement for Microencapsulation Device
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bayer Opens New Research and Innovation Center at Kendall Square
    Lonza Names Maria Soler Nunez as Head, Group Operations
    Eurofins DiscoverX Opens Shanghai Office
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Dexlevo Introduces Beauty Treatment technique, ‘GOURI’
    Revision Skincare Exec Wins Ernst & Young Entrepreneur of the Year
    Latest Updates About Cosmoprof North America
    Happi

    Latest Breaking News From Happi

    L’Oréal’s Solution for Gray Hair, Scotch Porter's New President & Boots No. 7 Beauty Is Not for Sale
    SCOTUS EPA Ruling Won’t Impact General Regulatory Authority
    Toning Collection For Zero-Brass Blondes is New at Colorproof
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Flint OPS, Xerox and MNYPIA Top This Week’s News
    Azelis Acquires Chemical Partners, Adds to Leadership in Africa and Middle East
    International Paper Publishes 2021 Sustainability Report
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    UPM Raflatac boosts operations in US, All4Labels returns to HP and more
    Fedrigoni Self-Adhesives to exhibit at Labelexpo Americas for first time
    CELAB Europe wins Paper Recycling award
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: Lifetime Technical Achievement Award Presented to Richard Knowlson, Alkegen Completes Luyang Acquisition & More
    Glatfelter, Blue Ocean Closures Partner with Absolut
    What You’re Reading on Nonwovens-Industry.com
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—July 2
    NuVasive Inc. Opens Singapore Experience Center
    Pedicle Screw Systems Market to Top $3B in 2027
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: eMagin, Identiv, and Japan Display Top This Week’s Stories
    Epishine is Building a New Solar Cell Factory in Linköping, Sweden
    Toppan Establishes CVC Fund and Investment Management Company in the US

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login